Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (“Fosun Pharmaceutical” for short, stock code: 600196.SH,02196.HK) was established in 1994. It is a leading, innovation-driven international medical and health industry group in China. Its business areas strategically lay out the medical and health industry chain. Its directly operated businesses include pharmaceuticals, medical devices and medical diagnostics, medical health services, and covers the pharmaceutical business sector through participation in Sinopharm Holdings. Based in mainland China and expanding global business, the Group directly operates businesses including pharmaceuticals, medical devices and medical diagnostics, healthcare services, and covers the pharmaceutical business sector through participation in Sinopharm Holdings. It is mainly engaged in pharmaceutical manufacturing and R&D, medical services, medical devices and medical diagnostics, and pharmaceutical distribution and retail. Among them, pharmaceutical manufacturing and research and development are the core, and medical services are the focus of development. Corporate honors: 2018 World's Best Employers List, 2018 China Pharmaceutical Industry Enterprise Group Top 10, 2018 Asia's Top 50 Best Listed Companies List, 2017 China Pharmaceutical Industry Top 100 List, 2017 China Pharmaceutical Industry Top 100 List, 2018 China's Top 30 Private Listed Companies for High-Quality Development, 2018 China's Top 30 Private Listed Companies for Social Responsibility, 2018 China's Top 30 Private Listed Companies for Social Responsibility, etc.
No Data